Isotopia
Isotopia Molecular Imaging is an Israel-based global pharmaceutical and nuclear medicine manufacturing company with proven expertise in developing, manufacturing, and commercializing pioneering diagnostic and therapeutic products.  Established in 2007, Isotopia is finishing the buildout of its U.S. headquarters and state-of-the-art manufacturing facility in Indianapolis, Indiana.  The company plans to begin production of GMP-grade Lu-177 n.c.a. – a radioactive medical isotope used in pharmaceuticals for cancer treatment – for delivery to its customers by the end of 2024.
